Absorption |
Blood-Brain Barrier | BBB- | 0.9961 |
Human Intestinal Absorption | HIA- | 0.9270 |
Caco-2 Permeability | Caco2- | 0.8956 |
P-glycoprotein Substrate | Substrate | 0.5603 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9626 |
Non-inhibitor | 0.9971 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9689 |
Distribution |
Subcellular localization | Lysosome | 0.5707 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8297 |
CYP450 2D6 Substrate | Non-substrate | 0.8447 |
CYP450 3A4 Substrate | Non-substrate | 0.5825 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9253 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9402 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9401 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9399 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9884 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9998 |
Non-inhibitor | 0.9031 |
AMES Toxicity | Non AMES toxic | 0.9132 |
Carcinogens | Non-carcinogens | 0.5363 |
Fish Toxicity | High FHMT | 0.9722 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.7152 |
Honey Bee Toxicity | Low HBT | 0.7369 |
Biodegradation | Not ready biodegradable | 0.9844 |
Acute Oral Toxicity | IV | 0.6698 |
Carcinogenicity (Three-class) | Non-required | 0.6941 |